EUVIMEDEUVIMED entdecken
Crossref

ANG peptide-modified exosomes loaded with oleanolic acid target GPX4 for enhanced breast cancer brain metastasis therapy

Guanyou Huang, Yigong Wei, Xiaohong Hou, Xin Jia, Tong Yang, Shanshan Yu, Hongchuan Gan

Journal of Neuro-Oncology · 2026

DOI: 10.1007/s11060-025-05375-5 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Neuro-Oncology, 2026. Verfasst von Guanyou Huang und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurosurgery, The Second People's Hospital of Guiyang (Jinyang Hospital), No. 547 Jinyang South Road, Guanshanhu District, Guiyang, 550…. Hauptthemen laut MEDLINE: Oleanolic Acid, Exosomes, Brain Neoplasms, Breast Neoplasms. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 40 Literaturangaben. Gefördert von: Guizhou Provincial Eighth Batch of High-Level Innovative Talents Training Program in Guiyang, Guizhou Provincial Basic Research Program (Natural Science) General Program, Medical Research Union Fund for High-quality Health Development of Guizhou Province.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

PURPOSE: Breast cancer brain metastasis (BCBM) is a major clinical challenge due to the blood-brain barrier (BBB) restricting effective drug delivery, resulting in limited therapeutic options and poor prognosis. This study aims to develop ANG peptide-modified exosomes loaded with oleanolic acid (ANG-Exo-OA) to enhance brain-targeted delivery and investigate its anti-tumor mechanisms through GPX4-mediated ferroptosis in BCBM treatment. METHODS: Oleanolic acid was encapsulated into mesenchymal stem cell-derived exosomes via electroporation, with ANG peptide conjugated using thiol-maleimide chemistry. ANG-Exo-OA was characterized using nanoparticle tracking analysis, transmission electron microscopy, and Western blot. Biocompatibility was evaluated via cytotoxicity assays, hematoxylin and eosin staining, and serum biochemistry. Brain-targeting efficiency was assessed using an in vitro BBB model and in vivo imaging. Anti-tumor effects and GPX4 pathway involvement were examined in a Luc-labeled MDA-MB-231 BCBM mouse model using Western blot, malondialdehyde, glutathione assays, and GPX4 overexpression rescue experiments. Statistical analyses included t-tests and ANOVA. RESULTS: ANG-Exo-OA exhibited excellent biocompatibility, stability, and enhanced BBB penetration, with significant brain accumulation. It suppressed MDA-MB-231 cell proliferation, migration, and induced apoptosis, accompanied by decreased GPX4 expression and increased lipid peroxidation. In vivo, ANG-Exo-OA reduced tumor growth and promoted ferroptosis, effects reversed by GPX4 overexpression. CONCLUSION: ANG-Exo-OA represents a promising therapeutic strategy for BCBM, achieving enhanced brain-targeted delivery and effective GPX4-mediated ferroptosis induction in a TNBC model. While the findings highlight its potential value for BCBM treatment, further studies involving additional breast cancer subtypes and more clinically relevant models are required to determine its broader applicability.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Oleanolic AcidExosomesBrain NeoplasmsBreast NeoplasmsPhospholipid Hydroperoxide Glutathione PeroxidaseAnimalsFemaleHumansMiceBlood-Brain BarrierMice, NudeXenograft Model Antitumor AssaysPeptidesDrug Delivery SystemsMice, Inbred BALB CMDA-MB-231 Cells

Stichwörter der Autor:innen

ANG-modified exosomesBrain-targeted deliveryBreast cancer brain metastasisFerroptosisGPX4Oleanolic acid

Substanzen

Oleanolic AcidPhospholipid Hydroperoxide Glutathione PeroxidasePeptides

Autor:innen und Institutionen

  • Department of Neurosurgery, The Second People's Hospital of Guiyang (Jinyang Hospital), No. 547 Jinyang South Road, Guanshanhu District, Guiyang, 550081, China. guanyouhuang024410@163.com.
  • Department of Neurosurgery, The Second People's Hospital of Guiyang (Jinyang Hospital), No. 547 Jinyang South Road, Guanshanhu District, Guiyang, 550081, China.
  • Department of Integrated Traditional Chinese and Western Medicine, The Second People's Hospital of Guiyang (Jinyang Hospital), Guiyang, 550081, China.
  • Department of Neurocritical Care, The Second People's Hospital of Guiyang (Jinyang Hospital), Guiyang, 550081, China.

Förderung

  • Guizhou Provincial Eighth Batch of High-Level Innovative Talents Training Program in Guiyang
  • Guizhou Provincial Basic Research Program (Natural Science) General Program
  • Medical Research Union Fund for High-quality Health Development of Guizhou Province
  • Doctoral Research Initiation Funds Project of The Second People's Hospital of Guiyang (Jinyang Hospital)
  • Science and Technology Foundation of Guizhou Provincial Health Commission
  • Cultivation Project of the National Natural Science Foundation of China (NSFC) at Guizhou Medical University

Zitieren

APA

Huang, G., Wei, Y., Hou, X., Jia, X., Yang, T., Yu, S., & Gan, H. (2026). ANG peptide-modified exosomes loaded with oleanolic acid target GPX4 for enhanced breast cancer brain metastasis therapy. Journal of Neuro-Oncology. https://doi.org/10.1007/s11060-025-05375-5

Vancouver

Huang G, Wei Y, Hou X, Jia X, Yang T, Yu S, et al. ANG peptide-modified exosomes loaded with oleanolic acid target GPX4 for enhanced breast cancer brain metastasis therapy. Journal of Neuro-Oncology. 2026. doi:10.1007/s11060-025-05375-5

BibTeX
@article{Huang2026,
  author = {Huang, Guanyou and Wei, Yigong and Hou, Xiaohong and Jia, Xin and Yang, Tong and Yu, Shanshan and Gan, Hongchuan},
  title = {ANG peptide-modified exosomes loaded with oleanolic acid target GPX4 for enhanced breast cancer brain metastasis therapy},
  journal = {Journal of Neuro-Oncology},
  year = {2026},
  doi = {10.1007/s11060-025-05375-5}
}
Kostenlos starten →